Effects of lipo-prostaglandin E1 on random pattern flaps in rabbits

Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery

Volumn 30, Issue 1, 1996, Pages 23-28

  Kuwahara, Hiroaki ^a   Sugihara, Tsuneki ^a   Ohura, Takehiko ^a   Igawa, Hiroharu ^a   Yamamoto, Yuhei ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Flap; Prostaglandin E1; Random pattern

Indexed keywords

MICROSPHERE; PROSTAGLANDIN E1;

ANIMAL EXPERIMENT; ARTICLE; BLOOD FLOWMETER; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; RABBIT; SKIN BLOOD FLOW; SKIN FLAP SURVIVAL;

EID: 0029922238     PISSN: 02844311     EISSN: None     Source Type: Journal    
DOI: 10.3109/02844319609072400     Document Type: Article

References (19)

1. Allen JE, Valeri R. Prostaglandins in hematology. Arch Intern Med 1974; 133: 86-96.
2. Bergström S, Duner H, v. Euler US, Sjövall J. Observations on the effects of infusion of prostaglandin E in man. Acta Physiol Scand 1959; 45: 145-151.
3. 1 in man. Acta Med Scand 1968; 183: 423-430.
4. Fukui A, Maeda M, Mine T, Inada Y, Mizumoto S, Tamai S. Continuous local intraarterial infusion after prolonged arterial stasis in the fingers and toes. Microsurgery 1992; 13: 62-66.
5. 1 and other related compounds on experimental peripheral arterial occlusive disease in rats. Drugs Exp Clin Res 1986; 12: 917-921.
6. 1 on canine femoral arterial allografts. Transplant Proc 1992; 24: 1360-1362.
7. 1) to treat Raynaud's phenomenon associated with connective tissue disease: thermographic and subjective assessment. J Pharm Pharmacol 1991; 44: 442-444.
8. Knight KR, Lepore DA, O'Brien BM. Interrelationship between prostanoids and skin flap survival: A review. Prostaglandins Leukot Essent Fatty Acids 1991; 44: 195-200.
9. 1 is more effective, when incorporated in lipid microspheres, for treatment of peripheral vascular diseases in man. J Pharm Pharmacol 1983; 35: 666-667.
10. 1 to vascular lesions. Prostaglandins Leukot Essent Fatty Acids 1990; 41: 269-272.
11. 1 incorporated in lipid microspheres, in peripheral vascular disease secondary to connective tissue disorders. J Rheumatol 1987; 14: 97-101.
12. Morain WD, Pettit RJ, Rothkopf DM, Coombs DW. Augmentation of surviving flap area by intraarterial vasodilators administered through implantable pumps. Ann Plast Surg 1983; 11: 46-52.
13. Ono I, Ohura T, Murazumi M, Sakamura R, Chiba S. A study on the effectiveness of a thromboxane synthetase inhibitor (OKY-046) in increasing the survival length of skin flaps. Plast Reconstr Surg 1990; 86: 1164-1173.
14. Piper PJ, Vane JR, Wyllie JH. Inactivation of prostaglandins by the lungs. Nature 1970; 225: 600-604.
15. 1 applied area and flap survival rate. Br J Plast Surg 1992; 45: 465-468.
16. Sekhar NC. Effect of eight prostaglandins on platelet aggregation. J Med Chem 1970; 13: 39-44.
17. 1 incorporated in lipid microspheres on thrombus formation and thrombus disaggregation and its potential to target to the site of vascular lesions. Arzneimittelforschung 1986; 36: 1206-1209.
18. Suzuki K, Takahashi K, Matsuki Y et al. Fluorescent probe-labeled lipid microsphere uptake by human endothelial cells: a flow cytometric study. Jpn J Pharmacol 1992; 60: 349-356.
19. Yamamoto Y, Ohura T, Nohira K et al. Laser-flowgraphy: A new visual blood flow meter utilizing a dynamic laser speckle effect. Plast Reconstr Surg 1993; 91: 884-894.